Freedom Broker Initiates Coverage of AngioDynamics (ANGO) with Buy Recommendation

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Stocks ANGO Freedom Broker Initiates Coverage of AngioDynamics (ANGO) with Buy Recommendation April 07, 2026 — 08:05 pm EDT Written by George Maybach for Fintel-> Fintel reports that on April 6, 2026, Freedom Broker initiated coverage of AngioDynamics (NasdaqGS:ANGO) with a Buy recommendation.

Analyst Price Forecast Suggests 103.30% Upside As of March 28, 2026, the average one-year price target for AngioDynamics is $19.72/share. The forecasts range from a low of $16.16 to a high of $25.20. The average price target represents an increase of 103.30% from its latest reported closing price of $9.70 / share. See our leaderboard of companies with the largest price target upside. The projected annual revenue for AngioDynamics is 420MM, an increase of 33.82%. The projected annual non-GAAP EPS is 1.07, an increase of 48.44% from the prior forecast. What is the Fund Sentiment? There are 169 funds or institutions reporting positions in AngioDynamics. This is an decrease of 142 owner(s) or 45.66% in the last quarter. Average portfolio weight of all funds dedicated to ANGO is 0.24%, an increase of 157.04%. Total shares owned by institutions decreased in the last three months by 13.00% to 38,796K shares. The put/call ratio of ANGO is 1.83, indicating a bearish outlook. What are Other Shareholders Doing? Point72 Asset Management holds 2,825K shares representing 6.78% ownership of the company. In its prior filing, the firm reported owning 2,559K shares , representing an increase of 9.44%. The firm decreased its portfolio allocation in ANGO by 15.18% over the last quarter.

Systematic Financial Management holds 2,505K shares representing 6.01% ownership of the company. In its prior filing, the firm reported owning 2,571K shares , representing a decrease of 2.62%. The firm decreased its portfolio allocation in ANGO by 11.55% over the last quarter. Kotler Kevin holds 1,714K shares representing 4.11% ownership of the company. Armistice Capital holds 1,700K shares representing 4.08% ownership of the company. In its prior filing, the firm reported owning 1,636K shares , representing an increase of 3.76%. The firm decreased its portfolio allocation in ANGO by 4.19% over the last quarter.

Weber Capital Management holds 1,400K shares representing 3.36% ownership of the company. Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.Click to Learn MoreThis story originally appeared on Fintel. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags Stocks Fintel Fintel is a leading provider of financial data and insights for intelligent, data-driven investors. With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford. Check out our Unique Analysis of Insider Sentiment for AngioDynamics, Inc.-> Find out what the Options Markets think of AngioDynamics, Inc.-> See our take on AngioDynamics, Inc. Upcoming Earnings-> More articles by this source-> Stocks mentioned ANGO More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.